The Medical Advisor

Home › GLP-1 Hub By Dr. Frank Yap, MD | One Day Media Network | Published October 13, 2026 | Last updated: October 13, 2026 | Purpose: evidence and safety education, not individual medical advice Quick Answer As of October 2026, the FDA has approved two GLP-1 weight-loss pills, oral Wegovy (semaglutide 25 mg, December 2025) and Foundayo (orforglipron, April 1, 2026), alongside weekly injections such as Wegovy, Zepbound, Ozempic and Mounjaro. Retatrutide and CagriSema are not approved in the US. Compounded and gray-market GLP-1 products are not FDA-approved. Use a licensed prescriber and a regulated pharmacy. On this page Which GLP-1 medicines are approved in October 2026? Are GLP-1 pills as effective as injections? Retatrutide and CagriSema: what is known so far? Safety and side effects: what should patients know? Compounded, gray-market and research peptides: what are the risks? How strong is the evidence? (CEBM grades) Where to start: the complete GLP-1 evidence library Using...

Medically Reviewed by: Dr Frank Yap, MD | Written by: OneDayMD Editorial Team | Last Updated: October 2026 Quick Answer Berberine, psyllium husk, and curcumin have the best human clinical evidence among natural Ozempic alternatives, though their weight-loss effect is modest (roughly 1–4 kg over 2–6 months) compared with semaglutide's 15%+ body-weight reduction. Berberine works through glucose and lipid metabolism, not by activating GLP-1 receptors the way Ozempic does — so "nature's Ozempic" is a catchy label, not a mechanistic match. As of September 2026, prescription GLP-1 drugs have also gotten dramatically cheaper (Wegovy from $349/month, Zepbound from $299/month via manufacturer cash-pay programs) and now come in oral pill form, which changes the cost-based case for natural alternatives even as safety and sustainability concerns remain valid reasons to consider them. There are natural alternatives to Ozempic like berberine, curcumin, and psyllium husk. Oz...